Our Experts

We Engineer Breakthrough Value

Lumanity brings together a unique and diverse team of 1200 deeply experienced industry pioneers, data luminaries, subject matter experts, and proven problem-solvers. Meet the experts that deliver breakthrough value and help accelerate access to the treatments that transform lives.

Jonathan Kowalski, Executive VP, Head of US HEOR at Lumanity

Whitepaper Learnings and Advice From the First Two Rounds of Medicare Drug Price Negotiations

Lumanity experts share insights, challenges, and best practice from supporting five of the first 25 drugs to undergo MDPN.

Jul 8, 2025

Our Experts

Ron Akehurst BSc, DSc, MFPH Chairman, HEOR

Jane Ayton Senior Vice President, Strategic Client Partnerships

Sam Barnes Senior Vice President, Growth Strategy

Richard Birnie PhD Vice President, Research, HEOR

Helen Blaszczok Head of Online Communities, Insight

Jeffrey M. Bockman PhD Expert Advisor, Executive Vice President, Oncology

Naomi Boxall PhD, MVSc General Manager, The PHARMO Institute

Zoe Brown Principal, Strategy Consulting

Melissa Brunckhorst PhD Vice President, Medical Services, Communications

GP Carlo Managing Consultant, Strategy Consulting

Lisa Cashman PharmD Vice President, Strategic Payer Content, Market Access

A man in hiking gear summiting a peak at sunrise

Whitepaper Integrated Evidence Generation Planning: A Strategic Imperative for Biopharma Innovation

Explore best-practice considerations for integrated evidence generation planning (IEGP) enriched with real-world case studies that illustrate the consequences of both success and failure in evidence planning. Learn how a strategic approach can transform evidence from a cost center to a strategic accelerator – cutting costs, shortening time-to-evidence, and boosting stakeholder trust with unified narratives validated by real-world impact.

Aug 5, 2025 GP Carlo

On-Demand Webinar Early Alignment, Enduring Value: Future-Proofing Your TPP

Jul 30, 2025 Katie McCarthy, Carolina Lahmann PhD, Ginger Johnson PhD